DALLAS, August 14, 2014 /PRNewswire/ --
LifeScienceIndustryResearch.com offers Animal/Veterinary Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global Forecast to 2018 research report in its store. It says global animal vaccines market is in its growth phase and is poised to cross the $8 billion mark by 2018. The factors responsible for the growth of the market include increasing incidences of zoonotic diseases in humans; growing prevalence of animal diseases; and increasing investments by government bodies, animal welfare associations, and leading players. Another factor driving the growth in this space is the continuous innovations and introduction of new products in the market. Since 2012, more than 20 new products have been launched, showing the huge potential for growth in this arena. However, increasing maintenance costs for vaccines and the shift towards vegetarian food by consumers will restrict the growth of the market to some extent. With the growing awareness of animal health in emerging economies, new entrants as well as established players have huge opportunities by introducing novel vaccines like DNA and recombinant vaccines and by entering into emerging countries. The global market for animal vaccines is estimated to grow at a healthy CAGR of 8.1% and reach $8.6 billion by 2018.
The livestock vaccines segment dominates the animal/veterinary vaccines market with close to 37% share followed by porcine and poultry. The large share of these segments is attributed to their major use of animals related to the food industry (meat, chicken, eggs, and dairy products), which are considered as healthy sources of protein. However, the aquaculture and companion vaccine segments will witness a healthy growth rate in the near future. On the basis of technology, the animal vaccines market has segments like live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines technology will be the fastest-growing technology due to its cost effectiveness and easy production, rapid development against emerging diseases, and added thermo-stability between 4°C to 20°C in comparison with traditional vaccines.
The market is dominated by tier I players and is fairly consolidated with the top 5 players contributing close to 70% of the share. New entrants face high barriers in entering this market as it is a capital-intensive industry with strict regulations. Companies profiled in this veterinary / animal vaccines market research report include Bayer Healthcare, Biogenesis Bago S.A., Bioniche Animal Health Canada, Inc., Boehringer Ingelheim, Ceva (Ceva Sante Animale), Heska Corporation, Indian Immunologicals Ltd., Lohmann Animal Health International, Merck, Merial (Animal Health Division Of Sanofi), Novartis Animal Health, Inc., Protein Sciences Corporation, Virbac and Zoetis (Pfizer Animal Health). Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=6481 .
Europe accounts for the largest share of the animal vaccines market, followed by North America. Both markets are reaching the maturity phase of growth and will register mid single-digit growth rates for the next five years. Asia, parts of Africa, and LATAM are poised to grow at double-digit rates owing to the increasing investment opportunities for companies in these immature markets and due to the improving healthcare facilities for animals. Countries like China, India, Australia, and Brazil will be major contributors to the growth of the market. Rising maintenance costs for storage of vaccines, burden on manufacturers and distributors, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders and persistent economic slowdown to affect growth are few restraints of the industry discussed in this research. Opportunities for new entrants as well as current market players mentioned in this report include technological innovations like DNA vaccines, growing awareness of animal health in emerging economies and increasing investment opportunities in emerging and immature markets. Within the animal vaccines industry, following regulations have been discussed in this study: USDA Regulates Registration Process In U.S., EMEA Is The Apex Body For Approval Of Veterinary Vaccines In Europe, MAFF Regulates The Veterinary Medicinal Products (VMPS) In Japan and Vich Harmonizes The Registration Process In U.S., Europe And Japan.
This research report categorizes the global animal/veterinary vaccines market on the basis of products, animal diseases, and technology. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018. Each segment of the market is comprehensively analyzed at a granular level, by geography (Europe, North America, Asia, and the Rest of the World), to provide in-depth information on the global scenario. Comprehensive Table of Contents and more on this report is available at http://www.lifescienceindustryresearch.com/animalveterinary-vaccines-market-products-livestock-bovine-companion-canine-poultry-equine-diseases-rabies-distemper-foot-mouth-gumboro-avian-influenza-strangles-technology-live.html .
Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018 is a 274 pages research report published in May 2014. At present, the global antimicrobials and antibiotics market is driven by the growing need to preserve animal health owing to rising demand for animal proteins across the globe, and growing demand in the companion animals segment. Growing livestock population, increasing incidences of disease outbreaks and increase in the companion animal ownership are some of the factors driving the growth of this market to a certain extent. Besides the structural market drivers, there are strong geographic drivers for the growth of the animal antimicrobials and antibiotics market. The emerging markets are becoming increasingly attractive. The Asian and Latin American region form one of the most promising animal antimicrobials and antibiotics markets in the world. Developing countries such as China and India have a relatively high CAGR rate and are expected to witness significant market growth in the forecast period. The growth in these regions is mainly attributed to the rise in demand for animal protein products, along with an increase in the trend of companion animal ownership in these regions. 10 company profiles, 128 data tables and 40 figures supporting the market analysis can be explored along with comprehensive Table of Contents for this report at http://www.lifescienceindustryresearch.com/animal-antimicrobials-and-antibiotics-market-by-products-tetracyclines-penicillins-sulfonamides-aminoglycosides-animals-dog-poultry-swine-mode-of-delivery-premixes-oral-powders-and-soluti.html .
Medication Management Market by Systems (CPOE, CDSS, Automated Dispensing, Assurance Systems), Services (Medication Analytics, POC Verification, ADE Surveillance), Mode of Delivery (On-Premises, Web-Based, Cloud-Based) - Global Forecast to 2019 is an August 2014 publication of 300 pages. This industry is largely driven by the growing need to minimize medication errors in the healthcare systems, and government initiatives in both developed and developing economies to curtail soaring healthcare expenditures. Other benefits of medication management systems, such as automated inventory management are also contributing to the greater uptake of medication management solutions by healthcare providers across the globe. The medication management market has experienced strong growth over the past few years, and is further expected to grow at an approximate CAGR of 14%-16% during the forecast period of 2014 to 2019. Companies profiled in this report include Allscripts Healthcare Solutions, Inc., Carefusion Corporation, GE Healthcare (A Division Of General Electric Company), Siemens Healthcare (Subsidiary Of Siemens AG), McKesson Corporation, Cerner Corporation, Optum Inc., Quadramed Corporation, Omnicell, Inc. and Meditech. Read more on this report at http://www.lifescienceindustryresearch.com/medication-management-market-by-systems-cpoe-cdss-automated-dispensing-assurance-systems-services-medication-analytics-poc-verification-ade-surveillance-mode-of-delivery-on-premises-web-b.html .
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252